MUFG

French toll road operator APRR had been quiet in 2018 by its own standards, but it sold its first corporate bond deal of the year on Wednesday with a €500m long 11 year trade. It paid a low new issue premium for the deal, but lost a number of orders along the way.

Cement maker Semen Indonesia has mandated five banks for a $1.282bn bridge loan to support its acquisition of the local unit of Swiss firm LafargeHolcim.

Duke Energy Corp became the latest US utility to issue green bonds last week, when it priced a $1bn dual tranche offering.

After Volkswagen printed the biggest trade in its history the previous week, the company’s International Finance arm sold a six tranche dual-currency deal on Monday. In total, the company raised more than €14bn equivalent in a week.

Volkswagen printed the biggest trade in its history as high-grade corporate borrowers blitzed the dollar market in response to the results of the US mid-term elections.

UK hotel group InterContinental’s debut euro deal was the smallest of three new corporate bond deals on Thursday after Wednesday saw no new issuance. While Allergan and BMW sold multi-tranche deals, IHG’s deal had been well flagged and still received due attention from investors.

Barito Pacific and Bank Rakyat Indonesia have returned to the international loan market for new fundraisings.

State-owned mining company Indonesia Asahan Aluminium (Inalum) closed a $4bn bond this week, letting loans bankers off the hook from a planned bridge facility. Addison Gong reports.

Bank Rakyat Indonesia has mandated 13 banks for a $700m multi-tranche borrowing, breaking a three-year absence from the loan syndications market.

Shanghai Pharmaceutical Holding is raising a $655m dual-tranche facility to refinance a bridge loan that was used to support the acquisition of Cardinal Health (L).

MUFG has named Zahra Sadry as head of EMEA healthcare coverage, moving her over from the group’s strategic finance team, where she was the MD responsible for Germany, Austria and Switzerland.

Japan’s Takeda Pharmaceutical Co has signed $8.8bn-equivalent of loans as it continues to build up its cash pile to finance the $62bn acquisition of Ireland’s Shire.